Description
This polyclonal antibody is labeled with R-Phycoerythrin (PE) and can be used for immunofluorescent labeling of cellular EP2 receptor following permeabilization. R-PE absorption maxima occurs at 565>540>498 nm and the emission maximum occurs at 578 nm, however standard excitation by 488 nm lasers is sufficient to generate signal detected in the PE channel of flow cytometers. The biological effects of prostaglandin E2 (PGE2) are mediated through interaction with four distinct membrane-bound G-protein coupled EP receptors: EP1, EP2, EP3, and EP4.{1422,4345} Binding of PGE2 to the EP2 receptor results in an increase in adenylate cyclase activity with a subsequent increase in cAMP.{10096,5500} Pharmacologically, EP2 receptors mediate relaxation of smooth muscle and are distinguished from EP4 receptors by their sensitivity to the EP2 receptor selective agonist butaprost.{1422,4345,10096} The human EP2 receptor is comprised of 358 amino acids with a molecular mass of approximately 40,000.{10096} mRNA for the EP2 receptor is expressed in a variety of tissues including lung, placenta, spleen, intestine, kidney, and sensory neuron.{10096,5500,9050}
Synonyms: PGE2 Receptor 2|Prostaglandin E2 Receptor 2
Immunogen: Peptide from the C-terminal region of human EP2
Formulation: 100 µg of peptide affinity purified, PE labeled polyclonal antibody
Isotype:
Applications: FC and ICC
Origin:
Stability: 365 days
Application|Flow Cytometry||Application|Immunocytochemistry||Product Type|Antibodies|Polyclonal Antibodies||Research Area|Cardiovascular System|Kidney & Renal Disease||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway
